Walleye Capital
ZYME icon

Walleye Capital’s Zymeworks ZYME Stock Holding History

Walleye Capital’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-78
Closed -$1.95K – 5238
2026
Q1 		$1.95K Sell
78
-13,589
-99% -$322K ﹤0.01% 4238
2025
Q4 		$360K Buy
13,667
+13,591
+17,883% +$296K ﹤0.01% 3170
2025
Q3 		$1.3K Buy
+76
New +$1.09K ﹤0.01% 4367
2025
Q2 		– Sell
-247,959
Closed -$2.95M – 5128
2025
Q1 		$2.95M Sell
247,959
-204,845
-45% -$2.79M 0.01% 1152
2024
Q4 		$6.63M Buy
+452,804
New +$6.33M 0.02% 894
2024
Q3 		– Sell
-26,374
Closed -$224K – 5955
2024
Q2 		$224K Buy
+26,374
New +$235K ﹤0.01% 4217
2023
Q4 		– Sell
-11,468
Closed -$72.7K – 5618
2023
Q3 		$72.7K Buy
+11,468
New +$84.7K ﹤0.01% 4077
2022
Q3 		– Sell
-204,096
Closed -$1.08M – 3610
2022
Q2 		$1.08M Sell
204,096
-72,211
-26% -$437K 0.03% 608
2022
Q1 		$1.81M Buy
+276,307
New +$2.46M 0.05% 403

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Walleye Capital's ZYME Position: Q2 2026 in Review

Walleye Capital sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 78 shares — an estimated $1.95K sold.

Walleye Capital first reported a position in ZYME in Q1 2022 and held it in 9 quarters. The position peaked at $6.63M in Q4 2024. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Walleye Capital reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 78 Zymeworks shares in Q2 2026, an estimated $1.95K.
  • Walleye Capital first reported a position in Zymeworks in Q1 2022 and held it in 9 quarters.
  • Walleye Capital's Zymeworks position peaked at $6.63M in Q4 2024.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.